GLP-1 drugs like Ozempic and Wegovy are changing more than just waistlines—they're disrupting the grocery aisle. JMR Co-Editor Brett Gordon speaks with Sylvia Hristakeva (Cornell), Jura Liaukonyte (Cornell), and Leo Feller (Numerator) about their paper, "The No Hunger Games: How GLP-1 Medication Adoption is Changing Consumer Food Demand.” The study linked GLP-1 usage survey data to 150,000 households' purchase data, finding that grocery spending declines by approximately 5% within six months, concentrated in processed, calorie-dense categories. Spending reverts to pre-adoption levels upon stopping the medication. In the episode, you’ll hear how quickly the project came together and the challenges of working on such a high-profile topic.
Paper on SSRN: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=5073929
Paper at JMR: https://journals.sagepub.com/doi/10.1177/00222437251412834